Concepedia

Author

Kirsty Hicks

GlaxoSmithKline (United Kingdom)ORCID

Also Known As

K Hicks, K J Hicks, K. J. HICKS, K.J. Hicks, Kirsty Hicks, Kirsty J. Hicks

18

Publications

319

Citations

9

H-Index

39

Concepts

All Affiliations

GlaxoSmithKline (United Kingdom)Age UKPfizer (United States)University of ManchesterQueen Mary University of London
KH

About

Kirsty Hicks is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, pharmacotherapy, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

127

2

Health Sciences

1

1

13

3

Social Sciences

1

1

14

4

Allergy

1

1

66

5

Anesthesia

1

1

13

Kirsty Hicks

×

9

Publications

313

Citations

9

H-Index

YearCitations

Investigation of selective JAK1 inhibitor GSK2586184 for the treatment of psoriasis in a randomized placebo-controlled phase IIa study

Valerie J. Ludbrook, Kirsty Hicks, Kate Hanrott,

British Journal of Dermatology

2016

80

Safety, tolerability, efficacy and pharmacodynamics of the selective JAK1 inhibitor GSK2586184 in patients with systemic lupus erythematosus

Lesley Kahl, Jessal J. Patel, Mark Layton,

Lupus

2016

66

CCL20 neutralization by a monoclonal antibody in healthy subjects selectively inhibits recruitment of CCR6<sup>+</sup> cells in an experimental suction blister

Gerben Bouma, Stefano Zamuner, Kirsty Hicks,

British Journal of Clinical Pharmacology

2017

44

Safety, pharmacokinetics, pharmacodynamics, and bioavailability of GSK2018682, a sphingosine‐1‐phosphate receptor modulator, in healthy volunteers

Jianfeng Xu, Frank Gray, Alex Henderson,

Clinical Pharmacology in Drug Development

2013

34

RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients

John D. Isaacs, Sarah Brockbank, Ayako Wakatsuki Pedersen,

Scientific Data

2022

23

Neurokinin‐1 receptor antagonism in a human model of visceral hypersensitivity

Robert P. Willert, Anthony Hobson, Claire Delaney,

Alimentary Pharmacology & Therapeutics

2007

22

A Phase I/II Study of GSK525762 Combined with Fulvestrant in Patients with Hormone Receptor–positive/HER2-negative Advanced or Metastatic Breast Cancer

David W. Cescon, John Hilton, Serafín Morales,

Clinical Cancer Research

2023

17

Distinct neurophysiological profiles in irritable bowel syndrome

Naila Arebi, Dominic Bullas, George E. Dukes,

American Journal of Physiology-Gastrointestinal and Liver Physiology

2011

14

Neurophysiological evaluation of convergent afferents innervating the human esophagus and area of referred pain on the anterior chest wall

Anthony Hobson, Boris A. Chizh, Kirsty Hicks,

American Journal of Physiology-Gastrointestinal and Liver Physiology

2009

13

Page 1